The global colorectal cancer therapeutics market consists of drugs that are used for treating colorectal cancer such as colon cancer or rectal cancer. Cancer starts in the colon or rectum and is one of the most commonly diagnosed types of cancers globally. Colorectal cancer develops slowly through multiple genetic changes over many years. Symptoms

What is Minimal Residual Disease Testing? Minimal residual disease (MRD) refers to the small number of cancer cells that can remain in the body after cancer treatment such as chemotherapy or stem cell transplant. These residual cancer cells may not be detected by conventional clinical methods like imaging tests or physical exams, but can still r

Mesenchymal stem cells (MSCs) are multipotent stromal cells that can differentiate into a variety of cell types, including osteoblasts, chondrocytes, adipocytes, and muscle cells. Given their unique properties of self-renewal and multilineage differentiation potential, MSCs offer a promising source for cell-based regenerative medicine and tissue en

Pediatric Cardiac Surgery Drives Demand for Pediatric Perfusion Industry One of the primary growth factors for the pediatric perfusion market has been the rise in congenital heart defects (CHDs) which often require cardiac surgery. CHDs affect nearly 1 in 100 live births globally with over 800,000 children born each year requiring surgery or oth

Cupric Chloride: An essential chemical compound for many applications What is Cupric Chloride? Cupric chloride (CuCl2) is an ionic compound composed of copper and chlorine. It is a yellow-green crystalline solid that occurs naturally as the mineral nantokite. It is highly soluble in water and is commonly used in many industrial and lab processes.